Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration.
Lihua ChenYuxuan HuangBinhua DongYu GuYe LiWei CangPeng-Ming SunYang XiangPublished in: Journal of inflammation research (2022)
Research on FLT3LG provided insight into its critical function. Hence, the low expression of FLT3LG may be a valuable biomarker in CESC patients linked with immune infiltration.